Abstract
The enteroviruses are simple, naked viruses capable of causing severe neurological, respiratory, and systemic illnesses in immune-susceptible patients. Since the global eradication of the polioviruses, infections caused by other members of the enterovirus genus have risen rapidly in the past decade, causing high mortality and morbidity in infants and young children. In many countries, the numbered enteroviruses, such as EV-A71, EV-D68, and CV-A16 are treated as high threat pathogens due to their high rate of reemergence that result in periodically occurring outbreaks. In this chapter, we discuss various strategies for the treatment and prophylaxis of enteroviral infections caused by the numbered enteroviruses. The book chapter places emphasis on recent progress in vaccine development and the potential of novel antienteroviral compounds, particularly multivalent vaccines, and broad-spectrum therapeutics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
